Skip to main content
Top
Published in: Journal of Mammary Gland Biology and Neoplasia 2-3/2007

01-09-2007 | Preface

Breast Cancer Progression: Controversies and Consensus in the Molecular Mechanisms of Metastasis and EMT

Authors: Pamela Cowin, Danny R. Welch

Published in: Journal of Mammary Gland Biology and Neoplasia | Issue 2-3/2007

Login to get access

Excerpt

Breast cancer is the second most frequent form of female cancer and a major source of cancer death worldwide. Although breast cancer has long been part of the human condition, appearing in the writings of ancient Egyptians, modern breast cancer shows a disturbing statistical increase from 1 per 20 women in the 1960s to one in eight today [1]. Although early detection by mammography and adjuvant therapies has improved survival, the absence of good prognostic criteria continues to result in overtreatment of patients with benign disease and failure to identify and eliminate the source of metastatic breast cancer. …
Literature
2.
go back to reference Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005;65(14):5996–6000; discussion 6000-1.PubMedCrossRef Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005;65(14):5996–6000; discussion 6000-1.PubMedCrossRef
3.
go back to reference Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial–mesenchymal transition? Cancer Res 2005;65(14):5991–5; discussion 5995.PubMedCrossRef Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial–mesenchymal transition? Cancer Res 2005;65(14):5991–5; discussion 5995.PubMedCrossRef
4.
go back to reference Yang J, Mani SA, Weinberg RA. Exploring a new twist on tumor metastasis. Cancer Res 2006;66(9):4549–52.PubMedCrossRef Yang J, Mani SA, Weinberg RA. Exploring a new twist on tumor metastasis. Cancer Res 2006;66(9):4549–52.PubMedCrossRef
5.
go back to reference Thiery JP, Sleeman JP. Complex networks orchestrate epithelial–mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7(2):131–42.PubMedCrossRef Thiery JP, Sleeman JP. Complex networks orchestrate epithelial–mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7(2):131–42.PubMedCrossRef
6.
go back to reference Thiery JP. Epithelial–mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003;15(6):740–6.PubMedCrossRef Thiery JP. Epithelial–mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003;15(6):740–6.PubMedCrossRef
7.
go back to reference Huber MA, Kraut N, Beug H. Molecular requirements for epithelial–mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005;17(5):548–58.PubMedCrossRef Huber MA, Kraut N, Beug H. Molecular requirements for epithelial–mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005;17(5):548–58.PubMedCrossRef
8.
go back to reference Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2(2):76–83.PubMedCrossRef Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2(2):76–83.PubMedCrossRef
9.
go back to reference Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000;2(2):84–9.PubMedCrossRef Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000;2(2):84–9.PubMedCrossRef
10.
go back to reference Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002;62(6):1613–8.PubMed Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002;62(6):1613–8.PubMed
11.
go back to reference Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117(7):927–39.PubMedCrossRef Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117(7):927–39.PubMedCrossRef
12.
go back to reference Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. Embo J 1995;14(24):6107–15.PubMed Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. Embo J 1995;14(24):6107–15.PubMed
13.
go back to reference Behrens J, Mareel MM, Van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell–cell adhesion. J Cell Biol 1989;108(6):2435–47.PubMedCrossRef Behrens J, Mareel MM, Van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell–cell adhesion. J Cell Biol 1989;108(6):2435–47.PubMedCrossRef
14.
go back to reference Behrens J, Birchmeier W, Goodman SL, Imhof BA. Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. J Cell Biol 1985;101(4):1307–15.PubMedCrossRef Behrens J, Birchmeier W, Goodman SL, Imhof BA. Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. J Cell Biol 1985;101(4):1307–15.PubMedCrossRef
15.
go back to reference Cowin P, Rowlands TM, Hatsell SJ. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005;17(5):499–508.PubMedCrossRef Cowin P, Rowlands TM, Hatsell SJ. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005;17(5):499–508.PubMedCrossRef
16.
go back to reference Saffell JL, Walsh FS, Doherty P. Expression of NCAM containing VASE in neurons can account for a developmental loss in their neurite outgrowth response to NCAM in a cellular substratum. J Cell Biol 1994;125(2):427–36.PubMedCrossRef Saffell JL, Walsh FS, Doherty P. Expression of NCAM containing VASE in neurons can account for a developmental loss in their neurite outgrowth response to NCAM in a cellular substratum. J Cell Biol 1994;125(2):427–36.PubMedCrossRef
17.
go back to reference Williams EJ, Furness J, Walsh FS, Doherty P. Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron 1994;13(3):583–94.PubMedCrossRef Williams EJ, Furness J, Walsh FS, Doherty P. Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron 1994;13(3):583–94.PubMedCrossRef
18.
go back to reference Wheelock MJ, Soler AP, Knudsen KA. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia 2001;6(3):275–85.PubMedCrossRef Wheelock MJ, Soler AP, Knudsen KA. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia 2001;6(3):275–85.PubMedCrossRef
19.
go back to reference Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999;147(3):631–44.PubMedCrossRef Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999;147(3):631–44.PubMedCrossRef
20.
go back to reference Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000;148(4):779–90.PubMedCrossRef Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000;148(4):779–90.PubMedCrossRef
21.
go back to reference Hatsell SJ, Cowin P. Gli3-mediated repression of Hedgehog targets is required for normal mammary development. Development 2006;133(18):3661–70.PubMedCrossRef Hatsell SJ, Cowin P. Gli3-mediated repression of Hedgehog targets is required for normal mammary development. Development 2006;133(18):3661–70.PubMedCrossRef
22.
go back to reference Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP. Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther 2006;5(6):674–83.PubMedCrossRef Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP. Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther 2006;5(6):674–83.PubMedCrossRef
23.
go back to reference Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007;8(5):341–52.PubMedCrossRef Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007;8(5):341–52.PubMedCrossRef
Metadata
Title
Breast Cancer Progression: Controversies and Consensus in the Molecular Mechanisms of Metastasis and EMT
Authors
Pamela Cowin
Danny R. Welch
Publication date
01-09-2007
Publisher
Springer US
Published in
Journal of Mammary Gland Biology and Neoplasia / Issue 2-3/2007
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-007-9041-9

Other articles of this Issue 2-3/2007

Journal of Mammary Gland Biology and Neoplasia 2-3/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine